Skip to main content
Vyome Holdings, Inc logo

Vyome Holdings, Inc — Investor Relations & Filings

Ticker · HIND ISIN · US67424L2097 US Manufacturing
Open in API
Filings indexed 590 across all filing types
Latest filing 2026-05-29 Earnings Release
Country US United States of America
Listing US HIND

About Vyome Holdings, Inc

https://www.reshapelifesciences.com/oba…

Vyome Holdings, Inc. is a clinical-stage biotechnology company focused on developing a portfolio of assets for immuno-inflammatory and potential orphan diseases. The company utilizes an artificial intelligence (AI)-driven platform to accelerate its research and development pipeline. Its operations are structured to leverage innovation and R&D capabilities across both the United States and India.

Recent filings

Filing Released Lang Actions
CURRENT REPORT
Earnings Release Classification · 95% confidence The document is a U.S. SEC Form 8-K current report, specifically Item 2.02 “Results of Operations and Financial Condition,” which furnishes a press release announcing the company’s quarterly financial results. This matches the definition of an Earnings Release (ER): an initial announcement of quarterly/periodical financial results. Therefore, the filing is classified as ER. Q1 2026
2026-05-29 English
10-Q - Vyome Holdings, Inc (0001427570) (Filer)
Interim / Quarterly Report Q1 2026
2026-05-12 English
DEF 14A - Vyome Holdings, Inc (0001427570) (Filer)
Proxy Solicitation & Information Statement
2026-03-31 English
PRE 14A - Vyome Holdings, Inc (0001427570) (Filer)
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Proxy Statement filed on Schedule 14A with the SEC, related to the 2026 Annual Meeting of Stockholders of Vyome Holdings, Inc. It includes detailed information about proposals to be voted on, such as election of directors, amendment to the certificate of incorporation, auditor ratification, and advisory vote on executive compensation. The document is clearly a solicitation of proxies for the annual meeting and contains governance and voting information. It is not the Annual Report itself, nor an announcement of voting results, but the proxy materials sent to shareholders to inform and request votes. Therefore, the document fits the definition of Proxy Solicitation & Information Statement (PSI). The document length (15,000 characters) and content confirm it is the proxy statement, not a brief announcement or a report publication notice.
2026-03-20 English
8-K - VYOME HOLDINGS, INC (0001427570) (Filer)
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The content describes the entry into a material definitive agreement related to a Notes Purchase and Exchange Agreement involving Vyome Holdings, Inc. It includes details about the transaction, approvals by the board and audit committee, and references to exhibits including the full agreement and a press release. There are no financial statements or comprehensive financial data presented, nor is this an annual or quarterly report. The document is not a proxy statement, earnings release, or other specific report type. It is a regulatory filing announcing a material event. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length (8177 characters) and detailed content support this classification with high confidence.
2026-02-25 English
8-K - VYOME HOLDINGS, INC (0001427570) (Filer)
Investor Presentation Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC by Vyome Holdings, Inc. It includes a Regulation FD Disclosure and attaches a presentation (Exhibit 99.1) related to Phase 2 data for a drug candidate. The text explicitly states that the presentation is furnished pursuant to Regulation FD and Item 7.01 of Form 8-K. The document is not a full financial report but rather a current report disclosing material information and attaching investor presentation materials. The presence of a presentation attached as Exhibit 99.1 and the nature of the disclosure align with an Investor Presentation filing rather than a full Annual Report, Earnings Release, or other categories. Therefore, the appropriate classification is Investor Presentation (IP). The document length (8557 characters) supports that it is more than a brief announcement but not a full financial report. Confidence is high given the clear identification of the filing type and content.
2026-02-12 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.